Type 2 Diabetes Mellitus Completed Phase 3 Trials for Insulin peglispro (DB11567)

Also known as: T2DM / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Type Two / Type Two Diabetes Mellitus / NIDDM / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus Non-insulin-dependent / Type 2 Diabetes / Diabetes, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes (T2D) / Diabetes Mellitus´╝îType 2 / Diabetes Mellitus. Type 2 / Diabetes Mellitus Type 2 / Diabetes Mellitus Type-2 / Type-2 Diabetes Mellitus / Diabetes Mellitus 2 Type / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus, Type 2 (T2DM) / T2DM (Type 2 Diabetes Mellitus) / Type 2 Diabetes Mellitus (T2D) / Diabetes Mellitus, Type 2 / Type-2 Diabetes / Diabetes Type 2 / Type 2 Diabetes (T2DM) / Type II Diabetes / Diabetes, Type II / Type-II Diabetes Mellitus / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / Diabetes Type II / Type II; Diabetes / Diabetes Mellitus Type II / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02132637A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesTreatment
NCT01894568A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentTreatment
NCT01790438A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesTreatment
NCT01582451A Study of LY2605541 in Participants With Type 2 Diabetes MellitusTreatment
NCT01468987A Study in Participants With Type 2 Diabetes MellitusTreatment
NCT01435616A Study in Patients With Type 2 Diabetes MellitusTreatment